Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands”
Based on a summary of interviews with 18 experts, Verkerk et al defined the seven key factors that promoted lowvalue care, which included system, social, and knowledge factors. During the ongoing coronavirus disease 2019 (COVID-19) pandemic, these key factors have been influential due to the uncertainty of the disease at the beginning of the pandemic. Globally, several measures have been implemented to reduce low-value care practices and promote high-value care for COVID-19 patients. From huge multicenter, non-industry sponsored or multiplatform trials, to the use of social networks sites is an indispensable and effective way to disseminate medical information. Thanks to these measures, we have transformed a scenario of ignorance into an evidence-based medical scenario in less than a year. Verkerk and colleagues’ proposed key factors are an excellent framework for characterizing and highlighting the lessons that can be learnt from how we have fought against the pandemic and low-value practices.
Verkerk EW, Van Dulmen SA, Born K, Gupta R, Westert GP, Kool RB. Key factors that promote low-value care: views of experts from the United States, Canada, and the Netherlands. Int J Health Policy Manag. 2021. doi:34172/ijhpm.2021.53
Saini V, Garcia-Armesto S, Klemperer D, et al. Drivers of poor medical care. Lancet. 2017;390(10090):178-190. doi:1016/s0140-6736(16)30947-3
Corral-Gudino L. Treatment of the COVID-19 pandemic: preventing a missed opportunity. Rev Clin Esp (Barc). 2020;220(6):386-387. doi:1016/j.rce.2020.04.005
Watanabe JH, Kwon J, Nan B, Abeles SR, Jia S, Mehta SR. Medication use patterns in hospitalized patients with COVID-19 in California during the pandemic. JAMA Netw Open. 2021;4(5):e2110775. doi:1001/jamanetworkopen.2021.10775
Balaz D, Wikman-Jorgensen PE, Galvañ VG, et al. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID National Registry. J Clin Med. 2021;10(19):4610. doi:3390/jcm10194610
Calderón-Parra J, Muiño-Miguez A, Bendala-Estrada AD, et al. Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One. 2021;16(5):e0251340. doi:1371/journal.pone.0251340
Pessoa-Amorim G, Campbell M, Fletcher L, et al. Making trials part of good clinical care: lessons from the RECOVERY trial. Future Healthc J. 2021;8(2):e243-e250. doi:7861/fhj.2021-0083
Pan H, Peto R, Henao-Restrepo AM, et al. Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial results. N Engl J Med. 2021; 384(6):497-511. doi:1056/NEJMoa2023184
Riccioni L, Ingravallo F, Grasselli G, et al. The Italian document: decisions for intensive care when there is an imbalance between care needs and resources during the COVID-19 pandemic. Ann Intensive Care. 2021; 11(1):100. doi:1186/s13613-021-00888-4
Pramesh CS, Babu GR, Basu J, et al. Choosing Wisely for COVID-19: ten evidence-based recommendations for patients and physicians. Nat Med. 2021;27(8):1324-1327. doi:1038/s41591-021-01439-x
Cliff BQ, Avanceña ALV, Hirth RA, Lee SD. The impact of Choosing Wisely interventions on low-value medical services: a systematic review. Milbank Q. 2021;99(4):1024-1058. doi:1111/1468-0009.12531
Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19. N Engl J Med. 2021;385(9):790-802. doi:1056/NEJMoa2105911
Jung RG, Di Santo P, Clifford C, et al. Methodological quality of COVID-19 clinical research. Nat Commun. 2021;12(1):943. doi:1038/s41467-021-21220-5
Tangcharoensathien V, Calleja N, Nguyen T, et al. Framework for managing the COVID-19 infodemic: methods and results of an online, crowdsourced WHO technical consultation. J Med Internet Res. 2020;22(6):e19659. doi:2196/19659
Hofmann B. Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies. Health Econ Policy Law. 2021;16(4):473-488. doi:1017/s1744133121000037
Corral-Gudino, L. (2022). Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands”. International Journal of Health Policy and Management, 11(9), 1967-1970. doi: 10.34172/ijhpm.2022.6887
MLA
Luis Corral-Gudino. "Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands”". International Journal of Health Policy and Management, 11, 9, 2022, 1967-1970. doi: 10.34172/ijhpm.2022.6887
HARVARD
Corral-Gudino, L. (2022). 'Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands”', International Journal of Health Policy and Management, 11(9), pp. 1967-1970. doi: 10.34172/ijhpm.2022.6887
VANCOUVER
Corral-Gudino, L. Tools to Reduce Low-Value Care: Lessons From COVID-19 Pandemic; Comment on “Key Factors that Promote Low-Value Care: Views of Experts From the United States, Canada, and the Netherlands”. International Journal of Health Policy and Management, 2022; 11(9): 1967-1970. doi: 10.34172/ijhpm.2022.6887
)
